8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
	May 5, 2011 Date of Report (Date of earliest event reported)
	HESKA CORPORATION (Exact name of Registrant as specified in its charter)
Delaware		000-22427	77-0192527
(State or other jurisdiction of incorporation)		(Commission File Number)	(I.R.S. Employer Identification No.)
	3760 Rocky Mountain Avenue Loveland, Colorado 80538 (Address of principal executive offices, including zip code)
(970) 493-7272 (Registrant’s telephone number, including area code)
Not Applicable (Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):
[   ]  Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[   ]   Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[   ]   Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[   ]   Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 2.02                      Results of Operations and Financial Condition.

The information in this Current Report is being furnished and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

On May 5, 2011, Heska Corporation announced its financial results for the quarter ended March 31, 2011 and certain other information.  A copy of the press release announcing these financial results and certain other information is attached hereto as Exhibit 99.1.

Item 9.01                      Financial Statements and Exhibits.

  (c)           Exhibits.

The following exhibit is furnished with this report on Form 8-K:

99.1           Press Release dated May 5, 2011.

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

	HESKA CORPORATION a Delaware corporation
Dated:  May 5, 2011	By: /s/  Jason A. Napolitano                                                                          Jason A. Napolitano Executive Vice President, Chief Financial Officer and Secretary

EXHIBIT INDEX

Exhibit Number	Description
99.1	Press Release dated May 5, 2011

EX-99.1

Exhibit 99.1

FOR IMMEDIATE RELEASE

At Heska Corporation:

Jason Napolitano, Executive Vice President & CFO

(970) 493-7272, Ext. 4105

Heska Announces Q1 2011 Results

Operating Income for Quarter is Highest in Three Years

LOVELAND, CO, May 5, 2011 -- Heska Corporation (NASDAQ: HSKA, "Heska" or the "Company") today reported financial results for its first quarter ended March 31, 2011.

Highlights since January 1, 2011 include:

•           10% growth in year-over-year quarterly revenue

•           Growth in year-over-year quarterly revenue in both of the Company's operating segments

•           34% increase in year-over-year quarterly gross profit

•           42.5% Gross Margin – the highest quarterly level in three years

•           Over $1.5MM in operating income – the second highest quarterly operating income in Heska history

•           An operating expense increase of less than 1%

•           Continued net cash balance sheet position

•           Joe Aperfine employed as Executive Vice President, Sales and Marketing

•           Announcement of a new platform technology agreement

"We had a strong quarter with revenue growth,  margin expansion and an improved level of profitability.  Once again, our results met or exceeded our stated guidance in all areas," said Robert Grieve, Heska's Chairman and CEO.  "In addition, Joe Aperfine formally began as our new Executive Vice President, Sales and Marketing earlier this week.  We conducted an extensive search for this position and were highly impressed with Joe's experience, skills and track record of success.  We are excited by the potential for Joe's leadership of our commercial efforts."

Investor Conference Call

Management will conduct a conference call on Thursday, May 5, 2011 at 9:00 a.m. MDT (11:00 a.m. EDT) to discuss the first quarter 2011 financial results.  To participate, dial (877) 941-9205 (domestic) or (480) 629-9835 (international); the conference call access number is 4435526.  The conference call will also be broadcast live over the Internet at http://www.heska.com.  To listen, simply log on to the web at this address at least ten minutes prior to the start of the call to register, download and install any necessary audio software.  Telephone replays of the conference call will be available for playback until May 19, 2011.  The telephone replay may be accessed by dialing (800) 406-7325 (domestic) or (303) 590-3030 (international).  The webcast replay may be accessed from Heska's home page at www.heska.com until May 19, 2011.

About Heska

Heska Corporation (NASDAQ: HSKA) sells advanced veterinary diagnostic and other specialty veterinary products.  Heska's state-of-the-art offerings to its customers include diagnostic instruments and supplies as well as single use, point-of-care tests, pharmaceuticals and vaccines.  The company's core focus is on the canine and feline markets where it strives to provide high value products and unparalleled customer support to veterinarians.  For further information on Heska and its products, visit the company's website at www.heska.com.

Forward-Looking Statements

This announcement contains forward-looking statements regarding Heska's future financial and operating results. These statements are based on current expectations and are subject to a number of risks and uncertainties. Investors should note that there is an inherent risk in using past results, including trends, to predict future outcomes.  In addition, factors that could affect the business and financial results of Heska generally include the following: uncertainties related to Heska's ability to maintain a given level of profitability, or profitability at all; risks related to relying on a key individual or group of individuals; uncertainties regarding Heska's ability to successfully market and sell its products in an economically sustainable manner; risks regarding Heska's reliance on third-party suppliers such as minimum purchase requirements, which could have a significant adverse impact on Heska's financial position; uncertainties regarding Heska's reliance on third parties to whom Heska has granted substantial marketing rights to certain of Heska's existing products and whom may be large Heska customers, including Schering-Plough Animal Health Corporation which has exclusive rights to our heartworm preventive in the United States; competition; risks related to Heska's reliance on third parties to develop certain of Heska's future products; and the risks set forth in Heska's filings and future filings with the Securities and Exchange Commission, including those set forth in Heska's Annual Report on Form 10-K for the year ended December 31, 2010.

Financial Table Follows:

Consolidated Statements of Operations

In Thousands, Except per Share Amounts

(unaudited)

	Three Months Ended March 31,
	2010			2011
Revenue, net:
Core companion animal health	$	15,792			$	16,441
Other vaccines, pharmaceuticals and products		1,902				3,064
Total revenue, net		17,694				19,505
Cost of revenue		11,489				11,207
Gross profit		6,205				8,298
Operating expenses:
Selling and marketing		4,036				3,960
Research and development		457				331
General and administrative		2,200				2,467
Total operating expenses		6,693				6,758
Operating income (loss)		(488	)			1,540
Interest and other expense, net		173				23
Income (loss) before income taxes		(661	)			1,517
Income tax expense (benefit)		(330	)			601
Net income (loss)	$	(331	)		$	916
Basic net income (loss) per share	$	(0.06	)		$	0.18
Diluted net income (loss) per share	$	(0.06	)		$	0.17
Shares used for basic net income (loss) per share		5,216				5,232
Shares used for diluted net income (loss) per share		5,216				5,261

Balance Sheet Data

In Thousands (unaudited)

	December 31, 2010		March 31, 2011
Cash and cash equivalents	$	5,492	$	5,567
Total current assets		27,279		30,109
Property and equipment, net		5,486		5,105
Total assets		63,048		64,148
Line of credit		3,079		3,379
Total current liabilities		12,660		12,751
Stockholders' equity		45,798		46,876

###